drugset / Trial / NCT01050348
To Investigate the Role of Upstream High Dose Statin in STEMI
Phase 4
Completed
120 enrolled
The Western Pennsylvania Hospital
West Penn Allegheny Health System · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a double-blinded randomized placebo controlled trial investigating the role of upstream 80mg Atorvastastin-calcium in patients undergoing percutaneous intervention for acute STEMI.
Timeline
- Start
- 2009-06
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 80 mg | Oral |